Haleon | HLN

Stock Price
365.70
Daily Change
-1.50 -0.41%
Monthly
5.06%
Yearly
-6.16%
Q3 Forecast
363.73

Peers Price Chg Day Year Date
AstraZeneca 12,090.00 -98.00 -0.80% -4.89% Sep/06
Energizer 28.77 0.12 0.42% -7.64% Sep/05
Edgewell Personal Care 23.40 -0.18 -0.76% -38.61% Sep/05
Haleon 365.70 -1.50 -0.41% -6.16% Sep/05
Nestle 75.41 -0.48 -0.63% -13.86% Sep/05
L'Oréal 402.65 -1.75 -0.43% 4.98% Sep/06
Reckitt Benckiser 5,710.00 32.00 0.56% 27.28% Sep/06
Unilever 64.31 -0.66 -1.02% -1.45% Sep/05

Indexes Price Day Year Date
GB100 9208 -8.67 -0.09% 12.55% Sep/05
EU600 549 -0.88 -0.16% 8.42% Sep/05

Haleon PLC traded at 365.70 this Friday September 5th, decreasing 1.50 or 0.41 percent since the previous trading session. Looking back, over the last four weeks, Haleon lost 5.06 percent. Over the last 12 months, its price fell by 6.16 percent. Looking ahead, we forecast Haleon PLC to be priced at 363.73 by the end of this quarter and at 357.86 in one year, according to Trading Economics global macro models projections and analysts expectations.

Haleon plc is a consumer healthcare company. The Company''s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company''s digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.